NASDAQ | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 15.02% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 9.55% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 7.69% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 7.58% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 5.8% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 4.89% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.56% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.47% |
| ICLR | ICON PLC | Healthcare | Diagnostics & Research | 4.36% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.25% |
| BGNE | BeiGene Ltd | Healthcare | Biotechnology | 3.21% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.81% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 2.75% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 2.58% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 2.51% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.39% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 2.21% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 2.12% |
| QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 2.01% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.98% |
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.